Long-term interferon-alpha therapy induces autoantibodies against epidermis

Developmental Neuroscience

Volumn 192, Issue 1, 1996, Pages 50-55

  Fleischmanna, M ^a   Celerier P ^a   Bernardh, P H ^b   Litoux, P ^a   Dreno, B ^a  

^a HÔTEL DIEU   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Antiskin antibodies; Indirect immunofluorescence; Interferon ; Western blot

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; BASEMENT MEMBRANE ANTIBODY; PEMPHIGUS ANTIBODY;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KERATINOCYTE; MALE; MELANOMA; PRIORITY JOURNAL; SIDE EFFECT; T CELL LYMPHOMA;

EID: 0030060830     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000246315     Document Type: Article

References (34)

1. Rosenblatt HM, Bryson Y, Merignan T: Interferon: Immunobiology and clinical significance. UCLA Conference. Ann Intern Med 1982:96:80-83.
2. Edwards BS: Low doses of interferon alpha result in more effective clinical natural killer cell activation. J Clin Invest 1983:1908-1913.
3. Dreno B. Claudy A. Mcynadier J, et al: The treatment of 45 patients with cutaneous T-cell lymphoma with low doses of interferon alpha 2a and etretinate. Br J Dermatol 1991:125: 456-459.
4. Harfast B. Huddlestone J. Casali P. et al: Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis. J Immunol 1981;127:2146-2150.
5. Lipsky PS: The control of antibody production by immuno-modulatory molecules. Arthritis Rheum 1989;32:1345-1355.
6. Peters M, Arnbrus J. Zheleznyak A. et al: Effect of interferon alpha on immunoglobulin synthesis by human B cells. J Immunol 1986; 137:3153-3157.
7. Rodriguez MA. Prinz W. Sibitt W, et al: Alpha interferon increases immunoglobulin production in cultured human mononuclear leukocytes. J Immunol 1983;130:1215-1219.
8. Neubauer RH. Goldstein L, Rabin H. et al: Stimulation of in vitro immunoglobulin production by interferon alpha. J Immunol 1985; 134:299-304.
9. Teichmann JV, Sieber G, Wolf-Dieter L. et al: Immunosuppressive effects of recombinant interferon alpha during long term treatment of patients. Cancer 1989:63:1990-1993.
10. Peters M. Walling D. Kelly K, et al: Immu-ologic effects of interferon alpha in man: Treatment with human recombinant interferon alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis. J Immunol 1986;137:3147-3152.
11. Fleisher TA. Attallah A, Tosato G, et al: Interferon mediated inhibition of human polyclonal immunoglobulin synthesis. J Immunol 1982: 129:1099-1103.
12. Schalaby MR: Effects of bacteria-produced human alpha, beta, and gamma interferons on in vitro immune functions. Cell Immunol 1984;84:380-392.
13. Gislcr RH. Lindahl P, Grosser I: Effects of interferon on antibody synthesis in vitro. J Immunol 1974:113:438-444.
14. Parker MA, Mandel AD. Wallace JH. et al: Modulation of the human in vitro antibody response by human leukocyte interferon preparations. Cell Immunol 1981:58:464.
15. Stadler R. Muller R. Orfanos CE: Effect of recombinant alpha A-interfcron on DNA synthesis and differentiation of human kératinocytes in vitro. Br J Dermatol 1986:114: 273-277.
16. Hachisuka H. Okubo K. Karashima T. et al: Increase of DNA synthesis and expression of bullous pemphigoid antigen on normal human kératinocytes by addition of interferon (abstract). J Invest Dermatol 1989:93:554.
17. Prost C, Intrator L. Roujeau JC. et al: An antigenic extract of bovine longue for analysis of both pemphigus vulgaris and bullous pemphigoid antibodies by immunoblotting (abstract). J Invest Dermatol 1989:92:502.
18. Bernard P, Didierjean L. Denis F. et al: Heterogeneous bullous pemphigoid antibodies: Detection and characterization by immunoblot-ting when absent by indirect immunofluorescence. J Invest Dermatol 1989:92:171-174.
19. Camisa C. Helm TN. Liu YC, Valenzuela R. Allen C. Bona S. Larrimcr N, Korman NJ. et al: Paraneoplastic pemphigus: A report of 3 cases including one long term survivor. J Am Acad Dermatol 1992:27:547-553.
20. Anhalt GJ. Kim S. Stanley JR. et al: Paraneoplastic pemphigus. N F.ngl J Med 1990:323: 1729-1735.
21. Flores A. Olive A. Feliu E. etal: Systemic lupus erythematosus following interferon therapy. Br J Rheumatol 1994:33:787.
22. Shilling PJ. Kurzrock P. Kantarjian H. et al: Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 1991;68:1536-1537.
23. Wandl UB. Nagel M, May D. et al: Lupus like autoimmune disease induced by interferon therapy for myeloproliferative disorder. Clin Immunol Immunopathol 1992:65:70-74.
24. Graninger WB. Hassfeld W. Pessan BB. ct al: Induction of systemic lupus erythematosus by IFN y in a patient with rheumatoid arthritis. J Rheumatol 1991:18:1621-1622.
25. Ronnblom LE. Alm GV, Oberg KE: Possible induction of systemic lupus erythematosus by interferon alpha treatment in a patient with a malignant carcinoid tumor. J Intern Med 1990;227:207-210.
26. Becker JC. Winkler B. Klingens, et al: Anti-phospholipid syndrom associated with immunotherapy for patients with melanoma. Cancer 1994:73:1621-1624.
27. Ronnblom LE. Alm GV, Oberg KE: Autoimmunity after alpha interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991:115:178-183.
28. D'Hondt L. Delannoy A. Docquier C: Hypothyroidism and arthritis during interferon therapy. Clin Rheumatol 1993:12:415-417.
29. Seitz M. Frank M. Kirchner H: Induction of antinuclear antibodies in patient with rheumatoid arthritis receiving treatment with recombinant interferon gamma. Ann Rheum Dis 1988:47: 642-644.
30. Ramseur WL. Richards F, Duggan DB: A case of fatal pemphigus vulgaris in association with beta interferon and interleukin-2 therapy. Cancer 1989:63:2005- 2007.
31. Parodi A. Semino M. Gallo R. Rebora A: Bullous eruption with circulating pemphigus-like antibodies following interferon-alpha therapy. Dermatology 1993:186:155-157.
32. Niizcki H. Inamoto N, Nakamura K. et al: A case of pemphigus foliaceus after interferon a2a therapy. Dermatology 1994; 189: 129-130.
33. Blenkinsopp WK. Clayton RJ. Haffenden GP: Immunoglobulin and complement in normal skin. J Clin Pathol 1978:31:1143-1146.
34. Fabre VC, Lear S. Reichlin M. et al: Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence. Arch Dermatol 1991:127:1006-1011.